Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Vapreotide

😃Good
Catalog No. T13306Cas No. 103222-11-3
Alias RC160, BMY 41606

Vapreotide is an antagonist of the neurokinin-1 (NK1) receptor (IC50: 330 nM).

Vapreotide

Vapreotide

😃Good
Catalog No. T13306Alias RC160, BMY 41606Cas No. 103222-11-3
Vapreotide is an antagonist of the neurokinin-1 (NK1) receptor (IC50: 330 nM).
Pack SizePriceAvailabilityQuantity
50 mgInquiryBackorder
100 mgInquiryBackorder
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Vapreotide is an antagonist of the neurokinin-1 (NK1) receptor (IC50: 330 nM).
Targets&IC50
NK1R:330 nM
In vitro
In a concentration-dependent manner, Vapreotide attenuates the effect of SP on calcium release . The concentration required for Vapreotide to completely inhibit the effect of SP is about 100 times higher than that required for the NK1R antagonist aprepitant. The effect of Vapreotide on cell proliferation is mediated primarily by SSTR2. In order to further establish the NK1R antagonist effect of Vapreotide, U373MG cells are pretreated with SSTR2 selective antagonist CYN followed by incubation with Vapreotide and SP stimulation. The results show that pretreatment with CYN does not reverse the inhibitory effect of Vapreotide on SP-stimulated IL-8 mRNA expression. As compared to control MDM, limited HIV gag mRNA expression may indicate that Vapreotide can reduce HIV-1 replication in MDM. In addition, SP treatment (10 μM) reversed the inhibitory effect of pentoprofen on HIV-1 replication in MDM. This observation indicates that the inhibitory effect of Vapreotide on HIV-1 replication is most likely due to its interaction with NK1R.
AliasRC160, BMY 41606
Chemical Properties
Molecular Weight1131.38
FormulaC57H70N12O9S2
Cas No.103222-11-3
Relative Density.1.4 g/cm3
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
H2O: 60 mg/mL (53.03 mM)
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM0.8839 mL4.4194 mL8.8388 mL44.1938 mL
5 mM0.1768 mL0.8839 mL1.7678 mL8.8388 mL
10 mM0.0884 mL0.4419 mL0.8839 mL4.4194 mL
20 mM0.0442 mL0.2210 mL0.4419 mL2.2097 mL
50 mM0.0177 mL0.0884 mL0.1768 mL0.8839 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Vapreotide | purchase Vapreotide | Vapreotide cost | order Vapreotide | Vapreotide chemical structure | Vapreotide in vitro | Vapreotide formula | Vapreotide molecular weight